BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18634088)

  • 1. Oxidative renaturation of lysozyme at high concentrations.
    Hevehan DL; De Bernardez Clark E
    Biotechnol Bioeng; 1997 May; 54(3):221-30. PubMed ID: 18634088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative renaturation of hen egg-white lysozyme. Folding vs aggregation.
    De Bernardez Clark E; Hevehan D; Szela S; Maachupalli-Reddy J
    Biotechnol Prog; 1998; 14(1):47-54. PubMed ID: 9496669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inclusion body contaminants on the oxidative renaturation of hen egg white lysozyme.
    Maachupalli-Reddy J; Kelley BD; De Bernardez Clark E
    Biotechnol Prog; 1997; 13(2):144-50. PubMed ID: 9104038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative effect of artificial chaperones and guanidinium chloride on lysozyme renaturation at high concentrations.
    Dong XY; Shi JH; Sun Y
    Biotechnol Prog; 2002; 18(3):663-5. PubMed ID: 12052090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refolding kinetics of denatured-reduced lysozyme in the presence of folding aids.
    Dong XY; Huang Y; Sun Y
    J Biotechnol; 2004 Oct; 114(1-2):135-42. PubMed ID: 15464607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Guanidinium Chloride Concentration on the Renaturation of Denatured Lysozyme.
    Shi JH; Dong XY; Sun Y
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2001; 33(4):447-451. PubMed ID: 12040421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling and simulation of fed-batch protein refolding process.
    Dong XY; Shi GQ; Li W; Sun Y
    Biotechnol Prog; 2004; 20(4):1213-9. PubMed ID: 15296450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renaturation of Escherichia coli-derived recombinant human macrophage colony-stimulating factor.
    Tran-Moseman A; Schauer N; De Bernardez Clark E
    Protein Expr Purif; 1999 Jun; 16(1):181-9. PubMed ID: 10336876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial chaperone-assisted refolding of denatured-reduced lysozyme: modulation of the competition between renaturation and aggregation.
    Rozema D; Gellman SH
    Biochemistry; 1996 Dec; 35(49):15760-71. PubMed ID: 8961939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
    Vallejo LF; Rinas U
    Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renaturation of lysozyme--temperature dependence of renaturation rate, renaturation yield, and aggregation: identification of hydrophobic folding intermediates.
    Fischer B; Sumner I; Goodenough P
    Arch Biochem Biophys; 1993 Oct; 306(1):183-7. PubMed ID: 8215401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-detergent sulphobetaines: a new class of molecules that facilitate in vitro protein renaturation.
    Goldberg ME; Expert-Bezancon N; Vuillard L; Rabilloud T
    Fold Des; 1995; 1(1):21-7. PubMed ID: 9162136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the potential refolding yield of recombinant proteins expressed as inclusion bodies.
    Ho JG; Middelberg AP
    Biotechnol Bioeng; 2004 Sep; 87(5):584-92. PubMed ID: 15352056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renaturation of recombinant human neurotrophin-3 from inclusion bodies using a suppressor agent of aggregation.
    Suenaga M; Ohmae H; Tsuji S; Itoh T; Nishimura O
    Biotechnol Appl Biochem; 1998 Oct; 28 ( Pt 2)():119-24. PubMed ID: 9756741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme.
    Goldberg ME; Rudolph R; Jaenicke R
    Biochemistry; 1991 Mar; 30(11):2790-7. PubMed ID: 2007117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical analysis of lysozyme refolding kinetics.
    Buswell AM; Middelberg AP
    Biotechnol Prog; 2002; 18(3):470-5. PubMed ID: 12052061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technical refolding of proteins: Do we have freedom to operate?
    Eiberle MK; Jungbauer A
    Biotechnol J; 2010 Jun; 5(6):547-59. PubMed ID: 20518058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of denaturant and protein concentrations upon protein refolding and aggregation: a simple lattice model.
    Gupta P; Hall CK; Voegler AC
    Protein Sci; 1998 Dec; 7(12):2642-52. PubMed ID: 9865959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rate of chemical or thermal renaturation on refolding and aggregation of a simple lattice protein.
    Nguyen HD; Hall CK
    Biotechnol Bioeng; 2002 Dec; 80(7):823-34. PubMed ID: 12402328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards creatine kinase aggregation due to the cysteine modification at the flexible active site and refolding pathway.
    Mu H; Zhou SM; Yang JM; Meng FG; Park YD
    Int J Biol Macromol; 2007 Oct; 41(4):439-46. PubMed ID: 17673285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.